Walkner Condon Financial Advisors LLC Exact Sciences Corp Transaction History
Walkner Condon Financial Advisors LLC
- $459 Million
- Q2 2024
A detailed history of Walkner Condon Financial Advisors LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Walkner Condon Financial Advisors LLC holds 8,441 shares of EXAS stock, worth $382,377. This represents 0.08% of its overall portfolio holdings.
Number of Shares
8,441
Previous 12,281
31.27%
Holding current value
$382,377
Previous $848,000
58.02%
% of portfolio
0.08%
Previous 0.18%
Shares
15 transactions
Others Institutions Holding EXAS
# of Institutions
683Shares Held
156MCall Options Held
5.76MPut Options Held
2.58M-
Vanguard Group Inc Valley Forge, PA17.7MShares$804 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA13MShares$590 Million0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY12.4MShares$561 Million0.08% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$515 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$484 Million0.13% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.02B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...